abstract |
Provided by the present application are a pharmaceutical composition comprising a polypeptide compound and a preparation method therefor, the polypeptide compound having peripheral kappa opioid receptor agonistic activity. Therefore, the present application also relates to the use of the pharmaceutical composition in preparing a drug for the prevention or treatment of kappa opioid receptor-related diseases. |